Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells (Q40539899)

21 September 2017

Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells (English)

1 reference

21 September 2017

William David Foulkes

2

1 reference

21 September 2017

7

Meenhard Herlyn

1 reference

21 September 2017

Ala-Eddin Al Moustafa

1

1 reference

21 September 2017

Annick Wong

3

1 reference

21 September 2017

Houda Jallal

4

1 reference

21 September 2017

Gerald Batist

5

1 reference

21 September 2017

Qunyan Yu

6

1 reference

21 September 2017

Piotr Sicinski

8

1 reference

21 September 2017

Moulay A Alaoui-Jamali

9

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

21 September 2017

1 reference

21 September 2017

23

1 reference

21 September 2017

30

1 reference

21 September 2017

5252-5256

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207679

21 September 2017

0 references

cites work

E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

The p53 network in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

Expression of vascular endothelial growth factor in adenocarcinomas of the uterine cervix and its relation to angiogenesis and p53 and c-erbB-2 protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

Cyclin D1 provides a link between development and oncogenesis in the retina and breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

Immunohistochemical analysis of the oncoprotein c-erbB-2 expression in oral benign and malignant lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

Specific protection against breast cancers by cyclin D1 ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

7 January 2021

Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

7 January 2021

Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

7 January 2021

Overexpression of cyclin D2 is associated with increased in vivo invasiveness of human squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

7 January 2021

Identification and typing of human papillomavirus (HPV) in squamous cell carcinoma of the oral cavity and oropharynx

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207679

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207679

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference